NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions: Chronic Disease, Immunocompromised, HIV Infection, Chronic Kidney Disease, Solid Organ Transplantation
Interventions: Hospital-Based Vaccination Pathway
AMBU-VAX is a prospective, single-center observational study designed to develop and implement an organizational model for delivering recommended vaccinations within a hospital setting. The study targets adult and elderly patients with chronic diseases or immunocompromising conditions who are eligible for vaccination according to national immunization guidelines. Vaccination is actively proposed during outpatient visits, hospital admissions, or at discharge and, when accepted, administered within the hospital or coordinated with local public health vaccination services. The study aims to evaluate the feasibility, uptake, and completion of hospital-based vaccination pathways and to support integration between hospital and territorial prevention services for vulnerable populations.
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Adults aged ≥18 years * Presence of at least one chronic or immunocompromising condition eligible for vaccination according to national guidelines * Written informed consent provided Exclusion Criteria: * Age \<18 years * Conditions not included among the predefined eligibility criteria